Skip to main content
Clinical Trials/NCT00175942
NCT00175942
Unknown
N/A

Indicators of Coagulation Activation and Inflammation Contributing to Ventricular Fibrillation Complicating Acute Myocardial Infarction

Heidelberg University1 site in 1 country300 target enrollmentFebruary 2003

Overview

Phase
N/A
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
Heidelberg University
Enrollment
300
Locations
1
Last Updated
20 years ago

Overview

Brief Summary

Sudden cardiac death is in most cases triggered by ischemia-related ventricular tachyarrhythmias and accounts for 50% of deaths from cardiovascular disease in developed countries. Chronic elevation of indicators of coagulation activation has been found in patients with coronary heart disease , but a role of coagulation activation and proinflammatory state as a potential risk factor for ventricular fibrillation (VF) during acute myocardial infarction has not been investigated.

Detailed Description

Sudden cardiac death (SCD) is in most cases triggered by ischemia-related ventricular arrhythmias and is responsible for 50% of the mortality from cardiovascular disease in developed countries (1). Chronic elevation of indicators of coagulation activation and inflammation has been found in patients with coronary heart disease and may contribute to vasculatory disorders probably contributing to the development of arrhythmogenesis. However, the role of coagulation activation as a potential risk factor for ventricular fibrillation during acute myocardial infarction has not been investigated yet.

Registry
clinicaltrials.gov
Start Date
February 2003
End Date
TBD
Last Updated
20 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ST-elevation myocardial infarction ventricular fibrillation during acute MI

Exclusion Criteria

  • NSTEMI coagulation disorders, e.g.intake of coumadin

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials